vol
pp
doi
j-x
patenting
pharmaceutical
invention
second
medical
us
brazil
viviane
yumy
mitsuuchi
kunisawa
max
planck
institute
intellectual
property
competition
tax
law
munich
center
current
brazilian
industrial
may
allows
patent
along
agreement
trade
related
aspect
right
provision
since
amendment
legislation
two
governmental
authority
instituto
nacional
da
propriedade
ageˆ
ncia
de
vigilaˆ
sanita´
ria
concomitantly
acting
patentgranting
procedure
ofﬁce
usually
responsible
examination
granting
agency
primarily
marketing
approval
drug
peculiar
situation
institution
denial
application
often
divergent
position
patentability
claiming
use
example
purpose
work
analyze
patent-granting
system
ﬁeld
special
focus
debate
question
whether
existing
conﬂicts
harmful
keywords
developing
new
led
advance
technology
aspirin
viagra
cited
showing
development
already
substance
technically
commercially
valuable
foundation
fox
et
al
number
food
administration
according
approved
contained
molecular
entity
also
illustrate
signiﬁcance
research
area
seen
tool
foster
investment
active
ingredient
well
ﬁnance
clinical
trial
needed
case
product
claim
devised
describe
protection
sought
paterson
entitles
inventor
privilege
teaching
speciﬁc
therapeutic
straus
term
ﬁrst
refers
medicinal
known
yet
used
contrast
describes
indication
third
hereinafter
simply
referred
enacted
equate
national
prohibit
however
regarded
suspiciously
argued
detrimental
access
medicine
population
basso
speciﬁcally
accused
lacking
novelty
unduly
extending
frequently
covering
brand
innovative
so-called
evergreening
practice
correa
context
attention
paid
conﬂicting
opinion
sanitary
surveillance
granted
intervene
require
prior
allowing
adopted
policy
deny
subject
matter
present
general
discus
competence
process
introduced
following
discussion
analyzes
handled
understanding
ﬁnally
confer
uncertainty
choice
allow
could
country
economic
technological
constitutional
guarantee
federal
constitution
establishes
shall
ensure
temporary
author
creation
keeping
mind
social
interest
interpret
clause
ﬁnalistic
meaning
goal
would
condition
conform
barbosa
justifying
existence
reﬂecting
compromise
society
regulated
infra-constitutional
guide
activity
public
oswald
leonardo
entered
force
regulate
implement
aim
observing
obligation
assumed
government
signing
patentable
provided
meet
inventive
step
disclosure
requirement
set
forth
article
furthermore
generic
classiﬁcation
eligible
category
enumerated
entitled
deﬁned
exclusion
belong
statutory
bar
lack
expressly
excluded
despite
fulﬁlling
unlike
previous
statute
december
chemical
ﬁelds
recognize
operating
surgical
technique
diagnostic
method
human
animal
body
competent
examining
created
concerning
facing
besides
another
called
regulatory
approving
must
provisional
measure
president
determining
submitted
issuance
requisite
ultimately
inserted
amending
february
accordingly
published
ordinance
august
changed
internal
regulation
within
addition
regulating
enumerates
consent
structure
division
record
hearing
congress
discussing
origin
recommendation
made
ministry
health
external
relation
industry
management
interministerial
justiﬁcation
pointed
need
assure
better
technical
standard
deciding
grant
similar
developed
without
legal
criterion
implementing
role
clearly
understood
expressed
rendered
solicitor
stated
regular
pipeline
exempted
revalidation
consist
validation
issued
abroad
ratifying
conducted
foreign
covered
available
examined
foreseen
transitory
mechanism
ﬁled
irrespective
accomplished
bearing
lick
deﬁning
decided
sent
end
concluded
comunicado
applied
judgment
opted
re-examine
completely
analyzed
checked
moreover
evaluation
analysis
compound
demand
rigorous
direct
impact
ﬁnal
cost
june
examine
established
request
applicant
action
submit
document
clariﬁcations
almost
year
delay
evidencing
capability
deal
crucial
decision
taken
based
important
notice
resolution
state
stick
margin
consideration
therefore
raise
argument
enablement
reﬂect
different
one
discussed
associac
brasileira
intelectual
association
applicable
among
non-commercialization
intervention
executive
blockage
pharmaceutical-related
souza
minimum
required
ground
sound
difﬁculties
constant
examiner
heading
towards
patent-friendly
approach
applying
saw
necessary
control
politically
performed
justiﬁed
discretionary
power
act
defense
represented
order
supremacy
welfare
individual
observes
function
mean
justice
serve
limitation
rodrigues
murphy
prevail
private
forgotten
relates
obtains
beneﬁts
content
directly
indirectly
enjoying
market
proﬁt
fostering
transfer
propitiated
stake
unconstitutional
fundamental
upon
fulﬁllment
principle
legality
space
represent
given
legislator
enact
instrument
administrator
attached
veriﬁed
industrially
supported
description
prohibited
payment
fee
otherwise
contra
legem
per
attorney
interesting
argue
observed
respect
determined
favor
restrict
involved
avoid
abusive
exercise
provides
beneﬁcial
unlimited
balance
carried
light
mentioned
occurs
stage
enforcement
harmed
due
prevailing
circumstance
thus
part
strictly
linked
considered
compulsory
license
ﬂexibilities
fact
efavirenz
treatment
merck
decree
november
judge
th
district
court
rio
janeiro
overruling
denying
valcyte
roche
differing
art
bad
unconstitutionality
interpretation
free
invalidated
rejecting
nulliﬁed
appeal
non-accomplishment
procedural
lawsuit
found
erred
expert
assist
ass
issue
intervening
scope
dealt
sustained
taxotere
cancer
aventis
pharma
exceeded
disclosed
original
violation
july
appellate
afﬁrmed
deemed
complex
requiring
administrative
give
coordinately
asserts
subjected
stringent
undue
high
importance
observe
above-mentioned
tends
conﬁrm
re-examining
harm
convincing
support
still
clear
cannot
discretionarily
like
absolute
rejection
political
level
bill
presented
house
representative
modify
proposal
restricted
object
international
allowed
enactment
nature
restriction
proposed
prompted
protest
resistant
losing
proceeding
argues
lenient
much
formenti
hand
concomitant
extends
open
door
meanwhile
change
participation
emphasize
always
ascertained
guideline
biotechnology
field
currently
deﬁne
medication
outside
referring
drafted
characterized
preparation
treat
illness
consists
described
swiss-type
form
prohibition
disease
drafting
ofﬁcial
nevertheless
opposite
regard
website
information
pharmaceuticalrelated
main
publishes
collegiate
board
scientiﬁc
hinder
violate
representing
discrimination
round
justify
prevent
proprietary
contrary
commercial
exploitation
line
legitimacy
doha
declaration
entitle
world
organization
member
adopt
promote
protect
exclude
arruda
cerdeira
contribute
innovation
result
empirical
observation
rather
dissemination
artiﬁcially
exclusive
holder
silent
dealing
implementation
adopting
recent
reviewing
organized
meeting
opened
practitioner
notorious
head
belief
contended
mostly
therapy
additionally
swisstype
enabled
speciﬁcation
possible
manufacture
certain
written
fulﬁlled
decade
ago
evidence
positioning
behind
reason
permissibility
reiterating
draft
recognizes
report
production
obvious
person
skilled
taking
account
relationship
etiology
targeted
suggest
parameter
admissible
wording
last
held
october
working
previously
take
remark
do
laborat
´orios
farmaceˆ
uticos
nacionais
laboratory
revision
little
nationally
therefrom
company
incremental
perform
containing
expense
comparatively
lower
initial
test
proving
safety
blocking
affected
identiﬁed
conﬂict
remarkable
aiming
include
justiﬁes
stating
deﬁnition
mere
discovery
fulﬁll
concludes
unjustiﬁed
extension
hinders
note
justiﬁcations
unclear
reiterated
increase
purchase
caˆ
mara
direction
afﬁrms
absence
september
intends
crystalline
kind
serving
barrier
enter
side
effect
adapting
pathology
treated
politician
commissioner
quote
manifestation
scientist
delimiting
concern
afﬁliated
advocated
ban
sector
legally
grounded
absent
met
reserved
prepared
conﬁrming
revealed
protected
directed
way
party
using
either
produce
domain
comprise
cure
prevention
alleviating
pain
suffering
re-establishment
normal
cover
analyzing
duly
documented
destroying
understand
evidently
derived
analogous
presenting
vivo
reference
enough
remember
notwithstanding
tendency
review
peremptorily
recently
time
leading
strattera
whose
tomoxetine
eli
lilly
indicated
deﬁcit
hyperactivity
disorder
although
medically
inventively
obtaining
prohibiting
shown
clariﬁes
finally
considers
understands
pending
ascertain
comprehension
regardless
early
maturity
peremptory
lacked
whereas
long
go
play
conclusion
especially
great
retrieve
contain
key
heartily
debated
consumer
increasing
price
exclusivity
undeserved
simple
criticizing
europe
unusual
questionable
forbids
illegal
evaluated
dispute
settlement
installment
involve
many
pleading
likely
never
occur
consider
totally
recognized
encourage
life-saving
excluding
even
lead
severe
consequence
assessment
struggle
establish
damaging
preclinical
molecule
studied
being
relate
relatively
chance
generate
risk
minimized
inventiveness
applicability
error
reassessment
opposition
judicial
re-examination
extensive
backlog
re-evaluate
jeopardizing
economical
progress
hindered
simplistic
fellow
candidate
¨at
attorney-at-law
e-mail
includes
assigned
japanese
tokyo
thank
prof
dr
dreshc
joseph
guidance
luciana
jansen
oliveira
figueiredo
m
maria
cec
´ılia
arau´
jo
renata
curzel
assistance
originally
prescribed
killer
cardiovascular
diabetes
sildenaﬁl
citrate
nowadays
highly
erectile
dysfunction
connection
dependent
portuguese
language
translated
english
ease
reader
regarding
bear
enjoys
hierarchy
follow
hierarchical
scale
together
presidential
come
subordinated
sufﬁciently
enable
carry
indicate
best
mode
execution
sole
biological
material
essential
practical
accessible
supplemented
deposit
authorized
characterizing
particularity
precisely
utility
model
theory
mathematical
purely
concept
scheme
plan
accounting
ﬁnancial
educational
publishing
lottery
ﬁscal
literary
architectural
artistic
aesthetic
computer
program
se
presentation
rule
game
natural
living
whole
including
genome
germ-plasm
isolated
moral
good
custom
security
mixture
element
modiﬁcation
physical-chemical
respective
modifying
transformation
atomic
nucleus
except
transgenic
micro-organism
three
organism
plant
exhibit
genetic
composition
characteristic
normally
attained
specie
january
empowers
legislate
relevance
urgency
succeeded
several
re-editions
aware
conditioning
equivalent
corresponding
gazette
code
communication
retroactively
afterwards
meantime
creates
acquired
problem
group
internationale
pour
la
propri
´et
´e
intellectuelle
accordance
originating
originated
contravene
monique
calmon
biolchini
patente
imerecida
reduz
campo
desenvolvimento
indu´
stria
utica
incluindo
pesquisa
cient
´ıﬁca
fabricac
irregular
estanca
´ıﬁco
impedindo
uma
maior
eﬁca´
cia
pol
´ıtica
pu´
blica
medicamentos
gen
´ericos
restringindo
acesso
populac
rem
´edios
mais
baratos
reduces
manufacturing
stay
hindering
larger
efﬁcacy
restricting
cheaper
guilherme
nogueira
gama
marcia
helena
nunes
clarify
alteration
limited
initially
type
ii
typical
newness
comprises
obviously
sense
occasionally
component
tablet
gel
injected
solution
etc
encompassed
display
consisting
swiss
formula
view
item
usual
avoiding
falling
followed
european
treating
administering
see
henrique
chvaler
edson
claro
nascimento
jos
carlos
vosgerau
marcus
keche
weber
´orio
catarinense
sintofarma
eurofarma
ltda
bollorini
pereira
ibid
status
online
accessed
governo
diverge
sobre
concessa˜o
segundo
uso
deputados
vigil
sanit
vigente
para
regulac
a˜o
brasil
april
esclarecimentos
pedidos
patentes
produtos
processos
farmaceˆuticos
longer
ﬁle
medicamento
sau´
jr
polido
ed
elsevier
alerta
´ecnico
resoluc
proibic
pela
reivindicac
e
utico
usucapia˜o
outros
estudos
lumen
juris
inconstitucionalidade
revista
journal
perspective
paper
anvisa
resiste
perda
poder
ana´
lise
estado
id=i
thadani
ma
nash
keating
czomiak
gillie
keltai
reduce
tolerance
men
chronic
stable
angina
heart
diretrizes
exame
na
a´reas
biotecnologia
farmaceˆutica
depositados
ap
´os
march
ata
completa
reunia˜o
grupo
´edico
menu-esquerdopatentediscussoes-tecnicasata-completa-da-a-reuniao-do-grupo-deestudos-sobre-segundo-uso-medicoi
a´rea
segundo-uso-medicoi
parecer
jur´ıdico
incrementalfarmaceuticadocviewi
patenteabilidade
nova
formas
cristalinas
substaˆncias
polim
´orﬁcas
novos
usos
´edicos
inovac
patenteabilidade-da-inovacao-farmaceutica-incrementali
exegese
lei
edic
medidas
provis
´orias
promulgac
direito
proposta
filtragem
constitucional
copyright
dialogue
united
albany
science
questo˜
atuais
em
patenta´
semina´
bra
calendar
potential